Fiduciary Trust’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Fiduciary Trust’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40,000	Closed	-$11K	–	644
2022 Q3	$11K	Hold	40,000	–	–	﹤0.01%	610
2022 Q2	$31K	Hold	40,000	–	–	﹤0.01%	623
2022 Q1	$43K	Hold	40,000	–	–	﹤0.01%	658
2021 Q4	$76K	Hold	40,000	–	–	﹤0.01%	648
2021 Q3	$120K	Hold	40,000	–	–	﹤0.01%	638
2021 Q2	$156K	Hold	40,000	–	–	﹤0.01%	626
2021 Q1	$203K	Hold	40,000	–	–	﹤0.01%	586
2020 Q4	$164K	Hold	40,000	–	–	﹤0.01%	562
2020 Q3	$194K	Hold	40,000	–	–	﹤0.01%	536
2020 Q2	$222K	Hold	40,000	–	–	0.01%	503
2020 Q1	$131K	Buy	+40,000	New	+$211K	﹤0.01%	482

Fiduciary Trust's AGTC Position: Q4 2022 in Review

Fiduciary Trust sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 40,000 shares — an estimated $11K sold.

Fiduciary Trust first reported a position in AGTC in Q1 2020 and held it in 11 quarters. The position peaked at $222K in Q2 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

Fiduciary Trust reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
Fiduciary Trust sold 40,000 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $11K.
Fiduciary Trust first reported a position in Applied Genetic Technologies Corporation in Q1 2020 and held it in 11 quarters.
Fiduciary Trust's Applied Genetic Technologies Corporation position peaked at $222K in Q2 2020.
0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Fiduciary Trust's 13F filing for Q4 2022, filed 14 Feb 2023.